Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension

International Journal of Cardiology

Volumn 202, Issue , 2016, Pages 388-393

  Hering, Dagmara ^a,b   Marusic, Petra ^a,b   Walton, Antony S ^c   Duval, Jacqueline ^a   Lee, Rebecca ^a   Sata, Yusuke ^a   Krum, Henry ^c,d   Lambert, Elisabeth ^a   Peter, Karlheinz ^a,c   Head, Geoff ^a   Lambert, Gavin ^a   Esler, Murray D ^a,c   Schlaich, Markus P ^a,b,d  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Renal artery anatomy; Renal denervation; Resistant hypertension

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM; SODIUM; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE CUFF; BLOOD PRESSURE MONITORING; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KIDNEY ARTERY; KIDNEY DENERVATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MUSCLE SYMPATHETIC NERVE ACTIVITY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RADIOFREQUENCY ABLATION DEVICE; RESISTANT HYPERTENSION; SAFETY; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; ADRENERGIC SYSTEM; ADVERSE EFFECTS; ANATOMY AND HISTOLOGY; ANGIOGRAPHY; BLOOD PRESSURE MEASUREMENT; CATHETER ABLATION; HYPERTENSION; INNERVATION; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SYMPATHECTOMY; TREATMENT OUTCOME; VASCULARIZATION;

AGED; ANGIOGRAPHY; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; RENAL ARTERY; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 84953261988     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.09.015     Document Type: Article

References (32)

1. R.J. Merklin, and N.A. Michels The variant renal and suprarenal blood supply with data on the inferior phrenic, ureteral and gonadal arteries: a statistical analysis based on 185 dissections and review of the literature J. Int. Coll. Surg. 29 1958 41 76
2. K. Khamanarong, P. Prachaney, A. Utraravichien, T. Tong-Un, and K. Sripaoraya Anatomy of renal arterial supply Clin. Anat. 17 2004 334 336
3. U. Ozkan, L. Oguzkurt, F. Tercan, O. Kizilkilic, Z. Koc, and N. Koca Renal artery origins and variations: angiographic evaluation of 855 consecutive patients Diagn. Interv. Radiol. 12 2006 183 186
4. A.G. Marshall Aberrant renal arteries and hypertension Lancet 2 1951 701 705
5. E.R. Davies, and D. Sutton Hypertension and multiple renal arteries Lancet 1 1965 341 344
6. G. Nomura, M. Kurosaki, T. Kondo, and J. Takeuchi Essential hypertension and multiple renal arteries Am. Heart J. 81 1971 274 280
7. B. Glodny, S. Cromme, P. Reimer, M. Lennarz, G. Winde, and H. Vetter Hypertension associated with multiple renal arteries may be renin-dependent J. Hypertens. 18 2000 1437 1444
8. A. Gupta, and R. Tello Accessory renal arteries are not related to hypertension risk: a review of MR angiography data AJR Am. J. Roentgenol. 182 2004 1521 1524
9. M. Esler, G. Lambert, and G. Jennings Increased regional sympathetic nervous activity in human hypertension: causes and consequences J. Hypertens. Suppl. 8 1990 S53 S57
10. G. Parati, and M. Esler The human sympathetic nervous system: its relevance in hypertension and heart failure Eur. Heart J. 33 2012 1058 1066
11. D. Hering, T. Kara, W. Kucharska, V.K. Somers, and K. Narkiewicz High-normal blood pressure is associated with increased resting sympathetic activity but normal responses to stress tests Blood Press. 22 2013 183 187
12. M.P. Schlaich, E. Lambert, D.M. Kaye, Z. Krozowski, D.J. Campbell, G. Lambert, and et al. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation Hypertension 43 2004 169 175
13. M. Johansson, M. Elam, B. Rundqvist, G. Eisenhofer, H. Herlitz, G. Lambert, and et al. Increased sympathetic nerve activity in renovascular hypertension Circulation 99 1999 2537 2542
14. D. Hering, E.A. Lambert, P. Marusic, A.S. Walton, H. Krum, G.W. Lambert, and et al. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension Hypertension 61 2013 457 464
15. D. Hering, P. Marusic, A.S. Walton, E.A. Lambert, H. Krum, K. Narkiewicz, and et al. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension Hypertension 64 2014 118 124
16. H. Krum, M.P. Schlaich, P.A. Sobotka, M. Bohm, F. Mahfoud, K. Rocha-Singh, and et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study Lancet 383 2014 622 629
17. M.D. Esler, M. Bohm, H. Sievert, C.L. Rump, R.E. Schmieder, H. Krum, and et al. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial Eur. Heart J. 34 2014 1752 1759
18. M.C. Brandt, F. Mahfoud, S. Reda, S.H. Schirmer, E. Erdmann, M. Bohm, and et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension J. Am. Coll. Cardiol. 59 2012 901 909
19. M.C. Brandt, S. Reda, F. Mahfoud, M. Lenski, M. Bohm, and U.C. Hoppe Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension J. Am. Coll. Cardiol. 60 2012 1956 1965
20. D. Hering, E.A. Lambert, P. Marusic, C. Ika-Sari, A.S. Walton, H. Krum, and et al. Renal nerve ablation reduces augmentation index in patients with resistant hypertension J. Hypertens. 31 2013 1893 1900
21. D. Hering, F. Mahfoud, A.S. Walton, H. Krum, G.W. Lambert, E.A. Lambert, and et al. Renal denervation in moderate to severe CKD J. Am. Soc. Nephrol. 23 2012 1250 1257
22. M.P. Schlaich, B. Bart, D. Hering, A. Walton, P. Marusic, F. Mahfoud, and et al. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease Int. J. Cardiol. 168 2013 2214 2220
23. A. Witkowski, A. Prejbisz, E. Florczak, J. Kadziela, P. Sliwinski, P. Bielen, and et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea Hypertension 58 2011 559 565
24. J.E. Davies, C.H. Manisty, R. Petraco, A.J. Barron, B. Unsworth, J. Mayet, and et al. First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study Int. J. Cardiol. 162 2013 189 192
25. D.L. Bhatt, D.E. Kandzari, W.W. O'Neill, R. D'Agostino, J.M. Flack, B.T. Katzen, and et al. A controlled trial of renal denervation for resistant hypertension N. Engl. J. Med. 370 2014 1393 1401
26. D.E. Kandzari, D.L. Bhatt, S. Brar, C.M. Devireddy, M. Esler, M. Fahy, and et al. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial Eur. Heart J. 36 2015 219 227
27. M.D. Esler, H. Krum, M. Schlaich, R.E. Schmieder, M. Bohm, and P.A. Sobotka Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial Circulation 126 2012 2976 2982
28. D. Id, B. Kaltenbach, S.C. Bertog, M. Hornung, I. Hofmann, L. Vaskelyte, and et al. Does the presence of accessory renal arteries affect the efficacy of renal denervation? JACC Cardiovasc. Interv. 6 2013 1085 1091
29. D. Hering, A. Walton, H. Krum, G.W. Lambert, M.D. Esler, and M.P. Schlaich Renal nerve ablation reduces blood pressure in a patient with renovascular hypertension resistant to drug and revascularisation therapies Int. J. Cardiol. 159 2012 e35 e36
30. G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, and et al. 2007 guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J. Hypertens. 25 2007 1105 1187
31. D.A. Calhoun, D. Jones, S. Textor, D.C. Goff, T.P. Murphy, R.D. Toto, and et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Hypertension 51 2008 1403 1419
32. G. Mancia, R. Fagard, K. Narkiewicz, J. Redon, A. Zanchetti, M. Bohm, and et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J. Hypertens. 31 2013 1281 1357